Skip to main content

Digitalis Ventures — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

72
Companies
$1.9B
Total invested
$27.6M
Avg. check
37
Industries
Biotechnology 13Medical 9Therapeutics 8Health Care 8Pet 4Software 4+31 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 72
Gallant
March 2025

Gallant is advancing investigational stem cell therapies to help give pets more good years, making regenerative care more accessible.

Biotechnology · San Diego$18.0M Series B
MoeGo
July 2024

MoeGo is a software solution designed for pet care business and professionals.

Mobile Apps · Los Angeles$500K Venture - Series Unknown
Expressable
May 2024

Expressable is an online speech therapy platform designed for individuals with communication disorders.

E-Learning · Austin$26.0M Series B
Cayaba Care
March 2024

Community-based, maternity program that provides wrap-around support throughout pregnancy and postpartum to improve maternal health outcomes

Health Care · Philadelphia$4.4M Venture - Series Unknown
Eden Brew
October 2023

Eden Brew is a food and beverage company that provides a range of animal-free and precision-fermented milk and dairy products.

Alternative Protein · Sydney$15.4M Series A
Companion
April 2023

Companion is a transformative learning experiences for your dog.

Artificial Intelligence (AI) · San Francisco$6.0M Venture - Series Unknown
Smalls
March 2023

Smalls offers high-quality, human-grade cat food made with fresh ingredients.

Animal Feed · New York$19.0M Series B
Switch Therapeutics
March 2023

Switch Therapeutics is a biotech company that develops RNAi therapies.

Biotechnology · San Francisco$52.0M Series A
EpiBiologics
January 2026

EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.

Biotechnology · San Mateo$107.0M Series B
Good Therapeutics
December 2021

Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.

Biotechnology · Seattle$8.0M Series B
Reema Health
December 2025

Reema Health is a technology startup transforming how people navigate the gaps between health care and social care.

Health Care · Minneapolis$19.0M Series B
Protego Biopharma
December 2025

Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.

Biopharma · San Diego$130.0M Series B
Candid
January 2022

CandidPro helps doctors provide clear aligner treatments to their patients via our comprehensive orthodontic platform.

Dental · New YorkSeries B
Kenzen
November 2023

Kenzen’s Mission is to harness the power of physiology data to predict and prevent industrial workforce injuries and improve productivity.

Analytics · Kansas City$58K Undisclosed
T-Therapeutics
November 2025

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.

Biotechnology · Cambridge$32.0M Series A
Judo Bio
October 2024

Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.

Biotechnology · Cambridge$75.0M Series A
Kingdom
October 2021

Kingdom creates and sells natural functional ingredients that actually work.

Biotechnology · BrooklynSeries A
Onc.AI
October 2024

Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.

Biotechnology · San Carlos$2.0M Grant
BIOMILQ
October 2021

Unlocking human potential with breakthrough mammary biotechnology.

AgTech · Durham$21.0M Series A
Scout Bio
October 2021

Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.

Biotechnology · Philadelphia$33.0M Series B
Matchpoint Therapeutics
October 2022

Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.

Biotechnology · Cambridge$70.0M Series A
Nadia Care
March 2026

Nadia Care is a maternal health company dedicated to supporting moms throughout their pregnancy and after their baby is born.

Health Care · Philadelphia$12.0M Series Unknown
ASTRA Therapeutics
July 2025

ASTRA Therapeutics is a medication development business that uses cutting-edge science and technology.

Health Care · Villigen$9.4M Seed
Galatea Bio
March 2025

Galatea Bio’s mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics.

Artificial Intelligence (AI) · Miami Lakes$8.0M Series Unknown

Where Digitalis Ventures invests

Biotechnology13
Medical9
Therapeutics8
Health Care8
Pet4
Software4

About Digitalis Ventures's portfolio

How many companies has Digitalis Ventures invested in?

Digitalis Ventures has invested in 72 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Digitalis Ventures invest in?

Digitalis Ventures's top investment sectors include Biotechnology, Medical, Therapeutics, Health Care, Pet. The firm invests across 37 different industry categories.

What is Digitalis Ventures's largest investment?

Among tracked funding rounds, Protego Biopharma received $130.0M in a Series B round. Digitalis Ventures's total known invested capital is $1.9B.

What is the average investment size for Digitalis Ventures?

Digitalis Ventures's average investment size is $27.6M across its portfolio of 72 companies.

What are Digitalis Ventures's most recent investments?

Recent Digitalis Ventures portfolio additions include Gallant, MoeGo, Expressable, Cayaba Care, Eden Brew. These companies were founded in 2020 or later.

Reach the founders behind these 72 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →